ducovest

0259-OL:HK:HK-YEEBO (INT'L H) (HKD)

COMMON STOCK | Other |

Last Closing

USD 2.28

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

There is no Profile data available for 0259-OL.HK. Address:

Currency: HKD

Country : Hong Kong

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
1863:HK China Longevity Group Company ..

N/A

 USD 1.17B
8355:HK I-CONTROL

-0.03 (-7.69%)

 USD 0.39B
8343:HK HongGuang Lighting Holdings Co..

-0.07 (-9.33%)

 USD 0.31B
0648:HK CHINA RENJ

N/A

 USD 0.12B
0177-OL:HK JIANGSU EXPRESS

-0.05 (-0.64%)

 N/A
0243-OL:HK QPL INT'L

+0.01 (+2.50%)

 N/A
0272-OL:HK SHUI ON LAND

N/A

 N/A
0182-OL:HK CHINA WINDPOWER

+0.01 (+1.92%)

 N/A
0287-OL:HK WINFAIR INV

N/A

 N/A
0239-OL:HK PAK FAH YEOW

N/A

 N/A

ETFs Containing 0259-OL:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -17.69% 25% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -17.69% 25% F 33% F
Trailing 12 Months  
Capital Gain -13.96% 35% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.96% 35% F 39% F
Trailing 5 Years  
Capital Gain 86.89% 83% B 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 86.89% 83% B 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 21.87% 84% B 80% B-
Dividend Return 21.87% 79% B- 79% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 26.56% 54% F 58% F
Risk Adjusted Return 82.34% 96% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike